NASDAQ:NTHI - Nasdaq - US64051A1016 - Common Stock - Currency: USD
NASDAQ:NTHI (5/20/2025, 8:21:38 PM)
7.25
-0.18 (-2.42%)
The current stock price of NTHI is 7.25 USD. In the past month the price increased by 21.24%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 54.29 | 708.16B | ||
JNJ | JOHNSON & JOHNSON | 15.29 | 369.72B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 19.6 | 302.74B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.51 | 221.76B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 18.8 | 216.78B | ||
MRK | MERCK & CO. INC. | 10.01 | 196.20B | ||
PFE | PFIZER INC | 7.33 | 133.39B | ||
SNY | SANOFI-ADR | 13.88 | 129.48B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 6.52 | 97.42B | ||
GSK | GSK PLC-SPON ADR | 7.01 | 77.70B | ||
ZTS | ZOETIS INC | 27.18 | 73.00B | ||
HLN | HALEON PLC-ADR | 22.49 | 49.69B |
NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in Calabasas, California. The company went IPO on 2025-03-26. The firm is focused on establishing treatments for intracranial malignancies, such as aggressive cancers located in the brain. The company is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company is developing novel drug delivery methods to be used in combination with novel drug candidates. The firm has two lead products in development: NEO100 and NEO212. NEO100 is a purified form of perillyl acid (POH) which is administered to brain cancer patients via intranasal delivery. NEO212 is a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol. NEO212 is undergoing development towards intranasal application specifically for patients with uncontrolled brain metastases derived from peripheral tumors (lung, breast, skin, and others).
NEONC TECHNOLOGIES HOLDINGS
23975 Park Sorrento, Suite 205
Calabasas CALIFORNIA US
Employees: 3
Phone: 13106637831
The current stock price of NTHI is 7.25 USD. The price decreased by -2.42% in the last trading session.
The exchange symbol of NEONC TECHNOLOGIES HOLDINGS is NTHI and it is listed on the Nasdaq exchange.
NTHI stock is listed on the Nasdaq exchange.
NEONC TECHNOLOGIES HOLDINGS (NTHI) has a market capitalization of 135.94M USD. This makes NTHI a Micro Cap stock.
NEONC TECHNOLOGIES HOLDINGS (NTHI) currently has 3 employees.
NEONC TECHNOLOGIES HOLDINGS (NTHI) has a resistance level at 7.5. Check the full technical report for a detailed analysis of NTHI support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NTHI does not pay a dividend.
NEONC TECHNOLOGIES HOLDINGS (NTHI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.63).
The outstanding short interest for NEONC TECHNOLOGIES HOLDINGS (NTHI) is 0.07% of its float. Check the ownership tab for more information on the NTHI short interest.
ChartMill assigns a technical rating of 4 / 10 to NTHI.
ChartMill assigns a fundamental rating of 1 / 10 to NTHI. NTHI has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months NTHI reported a non-GAAP Earnings per Share(EPS) of -0.63. The EPS increased by 20.26% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -348.19% | ||
ROE | N/A | ||
Debt/Equity | N/A |